These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
171 related articles for article (PubMed ID: 35191689)
21. Role of the familial Dutch mutation E22Q in the folding and aggregation of the 15-28 fragment of the Alzheimer amyloid-beta protein. Baumketner A; Krone MG; Shea JE Proc Natl Acad Sci U S A; 2008 Apr; 105(16):6027-32. PubMed ID: 18408165 [TBL] [Abstract][Full Text] [Related]
22. Structural heterogeneity in familial Alzheimer's disease mutants of amyloid-beta peptides. Chong SH; Yim J; Ham S Mol Biosyst; 2013 May; 9(5):997-1003. PubMed ID: 23358498 [TBL] [Abstract][Full Text] [Related]
23. Aggregation and catabolism of disease-associated intra-Abeta mutations: reduced proteolysis of AbetaA21G by neprilysin. Betts V; Leissring MA; Dolios G; Wang R; Selkoe DJ; Walsh DM Neurobiol Dis; 2008 Sep; 31(3):442-50. PubMed ID: 18602473 [TBL] [Abstract][Full Text] [Related]
24. Fusogenic properties of the C-terminal domain of the Alzheimer beta-amyloid peptide. Pillot T; Goethals M; Vanloo B; Talussot C; Brasseur R; Vandekerckhove J; Rosseneu M; Lins L J Biol Chem; 1996 Nov; 271(46):28757-65. PubMed ID: 8910517 [TBL] [Abstract][Full Text] [Related]
25. Two types of Alzheimer's beta-amyloid (1-40) peptide membrane interactions: aggregation preventing transmembrane anchoring versus accelerated surface fibril formation. Bokvist M; Lindström F; Watts A; Gröbner G J Mol Biol; 2004 Jan; 335(4):1039-49. PubMed ID: 14698298 [TBL] [Abstract][Full Text] [Related]
26. Elevation of beta-amyloid peptide 2-42 in sporadic and familial Alzheimer's disease and its generation in PS1 knockout cells. Wiltfang J; Esselmann H; Cupers P; Neumann M; Kretzschmar H; Beyermann M; Schleuder D; Jahn H; Rüther E; Kornhuber J; Annaert W; De Strooper B; Saftig P J Biol Chem; 2001 Nov; 276(46):42645-57. PubMed ID: 11526104 [TBL] [Abstract][Full Text] [Related]
31. A two-step strategy for structure-activity relationship studies of N-methylated aβ42 C-terminal fragments as aβ42 toxicity inhibitors. Li H; Zemel R; Lopes DH; Monien BH; Bitan G ChemMedChem; 2012 Mar; 7(3):515-22. PubMed ID: 22307963 [TBL] [Abstract][Full Text] [Related]
32. In vitro studies of amyloid beta-protein fibril assembly and toxicity provide clues to the aetiology of Flemish variant (Ala692-->Gly) Alzheimer's disease. Walsh DM; Hartley DM; Condron MM; Selkoe DJ; Teplow DB Biochem J; 2001 May; 355(Pt 3):869-77. PubMed ID: 11311152 [TBL] [Abstract][Full Text] [Related]
34. Destabilization of β-amyloid aggregates by thrombin derived peptide: plausible role of thrombin in neuroprotection. De D; Bhattacharjee P; Das H; Kumar KS; Biswas SC; Bhattacharyya D FEBS J; 2020 Jun; 287(11):2386-2413. PubMed ID: 31747135 [TBL] [Abstract][Full Text] [Related]
38. Physicochemical characteristics of soluble oligomeric Abeta and their pathologic role in Alzheimer's disease. Watson D; Castaño E; Kokjohn TA; Kuo YM; Lyubchenko Y; Pinsky D; Connolly ES; Esh C; Luehrs DC; Stine WB; Rowse LM; Emmerling MR; Roher AE Neurol Res; 2005 Dec; 27(8):869-81. PubMed ID: 16354549 [TBL] [Abstract][Full Text] [Related]
39. Engineering of a peptide probe for β-amyloid aggregates. Aoraha E; Candreva J; Kim JR Mol Biosyst; 2015 Aug; 11(8):2281-9. PubMed ID: 26073444 [TBL] [Abstract][Full Text] [Related]
40. A beta-amyloid peptide variant related with familial Alzheimer's disease and hereditary cerebral hemorrhage with amyloidosis is poorly eliminated by cathepsin D. Hamazaki H FEBS Lett; 1996 Nov; 397(2-3):313-5. PubMed ID: 8955370 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]